Literature DB >> 22833114

Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise.

Israel Ramirez-Sanchez1, Leonardo Nogueira, Aldo Moreno, Ann Murphy, Pam Taub, Guy Perkins, Guillermo M Ceballos, Michael Hogan, Moh Malek, Francisco Villarreal.   

Abstract

The consumption of moderate amounts of cocoa products has been associated with reductions in the incidence of cardiovascular diseases. In animal studies, the flavanol (-)-epicatechin (Epi) yields cardioprotection. The effects may be partly due to its capacity to stimulate endothelial nitric oxide synthase (eNOS). The sustained activation of eNOS, as observed with exercise, can serve as a trigger of muscle angiogenesis via the activation of vascular endothelial growth factor (VEGF)-related events. Experiments were pursued to examine the potential of Epi to stimulate myocardial angiogenesis and determine the effects that its combined use with exercise (Ex) may trigger. Hearts obtained from a previous study were used for this purpose. Animals received 1 mg/kg of Epi or water (vehicle) via oral gavage (twice daily). Epi and/or Ex (by treadmill) was provided for 15 days. Results indicate that Ex or Epi significantly stimulate myocardial angiogenesis by ~30% above control levels. The use of Epi-Ex lead to further significant increases (to ~50%). Effects were associated with increases in protein levels and/or activation of canonical angiogenesis pathway associated events (HIF1a, VEGF, VEGFR2, PI3K, PDK, AKT, eNOS, NO, cGMP, MMP-2/-9, Src-1, and CD31). Thus, the use of Epi may represent a safe and novel means to stimulate myocardial angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22833114      PMCID: PMC3496054          DOI: 10.1097/FJC.0b013e318269ae0d

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  32 in total

Review 1.  Angiogenesis in skeletal and cardiac muscle.

Authors:  O Hudlicka; M Brown; S Egginton
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

2.  Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart.

Authors:  F C White; C M Bloor; M D McKirnan; S M Carroll
Journal:  J Appl Physiol (1985)       Date:  1998-09

Review 3.  Flavanols for cardiovascular health: the science behind the sweetness.

Authors:  Naomi D L Fisher; Norman K Hollenberg
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

4.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium.

Authors:  L Morbidelli; C H Chang; J G Douglas; H J Granger; F Ledda; M Ziche
Journal:  Am J Physiol       Date:  1996-01

5.  Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor.

Authors:  Shigeaki Kaga; Lijun Zhan; Masahiko Matsumoto; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2005-09-29       Impact factor: 5.000

6.  Placenta growth factor is not required for exercise-induced angiogenesis.

Authors:  Bruna Gigante; Marina Tarsitano; Vincenzo Cimini; Sandro De Falco; M Graziella Persico
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

Review 7.  Determinants of maximal oxygen transport and utilization.

Authors:  P D Wagner
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

8.  Erythropoietin and VEGF exhibit equal angiogenic potential.

Authors:  Kai Jaquet; Korff Krause; Mona Tawakol-Khodai; Stefan Geidel; Karl-Heinz Kuck
Journal:  Microvasc Res       Date:  2002-09       Impact factor: 3.514

Review 9.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

10.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

Authors:  M Ziche; L Morbidelli; E Masini; S Amerini; H J Granger; C A Maggi; P Geppetti; F Ledda
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more
  10 in total

1.  Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function.

Authors:  Katrina Go Yamazaki; Aleksander Y Andreyev; Pilar Ortiz-Vilchis; Susanna Petrosyan; Ajit S Divakaruni; Sandra E Wiley; Christine De La Fuente; Guy Perkins; Guillermo Ceballos; Francisco Villarreal; Anne N Murphy
Journal:  Int J Cardiol       Date:  2014-05-15       Impact factor: 4.164

2.  Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins.

Authors:  Aldo Moreno-Ulloa; Armando Cid; Ivan Rubio-Gayosso; Guillermo Ceballos; Francisco Villarreal; Israel Ramirez-Sanchez
Journal:  Bioorg Med Chem Lett       Date:  2013-06-01       Impact factor: 2.823

3.  Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation.

Authors:  Gabriela Gutierrez-Salmean; Theodore P Ciaraldi; Leonardo Nogueira; Jonathan Barboza; Pam R Taub; Michael C Hogan; Robert R Henry; Eduardo Meaney; Francisco Villarreal; Guillermo Ceballos; Israel Ramirez-Sanchez
Journal:  J Nutr Biochem       Date:  2013-10-18       Impact factor: 6.048

4.  (-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor.

Authors:  Aldo Moreno-Ulloa; Adriana Miranda-Cervantes; Alexei Licea-Navarro; Christina Mansour; Ernesto Beltrán-Partida; Luis Donis-Maturano; Hilda C Delgado De la Herrán; Francisco Villarreal; Carolina Álvarez-Delgado
Journal:  Eur J Pharmacol       Date:  2018-01-20       Impact factor: 4.432

5.  Role of Chitinase-3-like Protein 1 in Cardioprotection and Angiogenesis by Post-Infarction Exercise Training.

Authors:  Zhuo Li; Fangnan Wu; Lei Xi; Zhenjun Tian
Journal:  Biomedicines       Date:  2022-04-29

6.  (-)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin-proteasome system.

Authors:  Cristian Gonzalez-Ruiz; Paola Cordero-Anguiano; Axayacatl Morales-Guadarrama; Rodrigo Mondragón-Lozano; Stephanie Sánchez-Torres; Hermelinda Salgado-Ceballos; Francisco Villarreal; Eduardo Meaney; Guillermo Ceballos; Nayelli Nájera
Journal:  Mol Biol Rep       Date:  2020-11-05       Impact factor: 2.316

Review 7.  Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration.

Authors:  Joseph Shay; Hosam A Elbaz; Icksoo Lee; Steven P Zielske; Moh H Malek; Maik Hüttemann
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

8.  (-)-Epicatechin combined with 8 weeks of treadmill exercise is associated with increased angiogenic and mitochondrial signaling in mice.

Authors:  Icksoo Lee; Maik Hüttemann; Adele Kruger; Aliccia Bollig-Fischer; Moh H Malek
Journal:  Front Pharmacol       Date:  2015-03-13       Impact factor: 5.810

Review 9.  Mitophagy Transcriptome: Mechanistic Insights into Polyphenol-Mediated Mitophagy.

Authors:  Sijie Tan; Esther Wong
Journal:  Oxid Med Cell Longev       Date:  2017-05-25       Impact factor: 6.543

Review 10.  Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Authors:  Iveta Bernatova; Silvia Liskova
Journal:  Antioxidants (Basel)       Date:  2021-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.